Clinical Trials Logo

Clinical Trial Summary

Primary objective is to is to evaluate the bioequivalence of two formulations


Clinical Trial Description

To evaluate the bioequivalence of two formulations of sacubitril/valsartan 49 mg/51 mg film coated tablets, Entresto® (Reference) and Sacubitril and Valsartan Tablets 49mg/51mg (Test), after a single oral dose administration in healthy Thai subjects under fasting conditions ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06273254
Study type Interventional
Source Viatris Inc.
Contact Arun Kumar, M.Pharm
Phone 9676300054
Email akumar@viatris.com
Status Not yet recruiting
Phase Phase 1
Start date April 2024
Completion date September 2024

See also
  Status Clinical Trial Phase
Completed NCT03050164 - Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions Phase 1
Completed NCT04877834 - Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects. Phase 1
Not yet recruiting NCT06058689 - A Pilot Bioequivalence Study of Pomalidomide Phase 1
Completed NCT05436769 - Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet Phase 1
Completed NCT04585321 - Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day Phase 1
Completed NCT04873570 - Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects Phase 1
Completed NCT01595425 - Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects Phase 1
Recruiting NCT05794919 - Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers N/A
Completed NCT04358770 - Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream Phase 1
Completed NCT03602300 - A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study Phase 1
Completed NCT05436886 - Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules N/A
Completed NCT01494402 - Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects Phase 1
Recruiting NCT04229602 - Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers N/A
Completed NCT03765944 - Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets Phase 1